OMER


OMER: Omeros Prices $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ:OMER) today announced that it has priced an underwritten public offering of 2,995,506 shares of its common stock at a per …

Wedbush Reiterates Outperform On Omeros Following Positive OMS721 Ex Vivo Results

Wedbush analyst Liana Moussatos reiterated an Outperform rating on Omeros (NASDAQ:OMER) with a $52 price target, after the company announced positive data using OMS721, the …

Omeros: We See Potential Upside In Transitional Pass-Through Reimbursement Of Omidria, Says MLV

MLV analyst George Zavoico assigned a Buy rating on Omeros (NASDAQ:OMER) with a $19 price target, as the company announced that the Center for …

Maxim Group Comments On Omeros Following Temporary Suspension Of OMS824 Huntington’s Disease Trial

In a research report issued today, Maxim Group analyst Jason Kolbert assigned a Buy rating on Omeros (NASDAQ:OMER) with a price target of …

Maxim Maintains Buy On Omeros Following New Commercial Supply Agreement

In a research report sent to investors today, analyst Jason Kolbert of Maxim Group maintained a Buy rating on Omeros (NASDAQ:OMER) with a $24 price target, …

Maxim Reaffirms Buy On Omeros Ahead Of 2Q14 Results, Sees 73% Upside

Maxim Group analyst Jason Kolbert provided an optimistic view on Omeros Corp. (OMER) heading into the company’s second-quarter earnings report, where it is …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts